A new treatment for amyotrophic lateral sclerosis (ALS) based on stem cell technology and now in clinical trials at the Hadassah University Medical Center, appears to have cured an Orthodox Rabbi in Israel who was diagnosed with the disease two years ago.
The Rabbi may be the first known patient cured of ALS. If the drug proves to be a viable treatment for ALS, the results would be game changing, and would help people afflicted with ALS across the world. "There is no doubt that a great drama is taking place here," said a Hadassah doctor.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>